What assessment finding is an indication that ipratropium is effective?

The effectiveness of ipratropium, an anticholinergic bronchodilator, is indicated by clear lung auscultation. Ipratropium works by relaxing the muscles of the airways, leading to dilation and reduced resistance in the respiratory tract. When the medication is effective, you should observe less bronchoconstriction, which translates to improved airflow and reduced wheezing or abnormal lung sounds during auscultation. Clear lung sounds signify that the airways are open and functioning well, indicating that the medication has successfully alleviated symptoms of obstruction or constriction.

In contrast, persistent coughing, increased respiratory effort, and chest tightness suggest ongoing airway resistance or exacerbation of underlying conditions, such as asthma or COPD. These findings would not reflect the desired outcome of ipratropium therapy, hence supporting the selection of clear lung auscultation as an indicator of therapeutic effectiveness.